30.20
+1.40
+(4.86%)
At close: January 16 at 10:15:01 AM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
153.00
153.00
968.00
3,247.00
802.00
Investing Cash Flow
-1,673.00
-1,673.00
-567.00
-740.00
-313.00
Financing Cash Flow
-2,683.00
-2,683.00
-1,612.00
-268.00
-1,600.00
End Cash Position
15,690.00
15,690.00
19,437.00
19,223.00
17,239.00
Capital Expenditure
-274.00
-274.00
-457.00
-659.00
-304.00
Issuance of Capital Stock
65.00
65.00
--
--
98.00
Issuance of Debt
--
--
--
593.00
--
Repurchase of Capital Stock
-1,744.00
-1,744.00
-256.00
--
-671.00
Free Cash Flow
-121.00
-121.00
511.00
2,588.00
498.00
12/31/2020 - 3/12/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IOB.DU Ion Beam Applications SA
12.98
-2.41%
8C4.F CYBERDYNE Inc.
1.0440
-0.19%
2SE.F Sequana Medical NV
2.5400
-1.17%
CYBQF CYBERDYNE Inc.
1.0350
0.00%
NEOLA.ST Neola Medical AB (publ)
2.5400
-0.78%
ABT.VI Abbott Laboratories
110.40
+0.84%
2SE.SG Sequana Medical NV
2.5400
-2.68%
EPIS-B.ST Episurf Medical AB (publ)
0.1318
-2.23%
P09.SG Pacific Biosciences of California Inc
1.5986
+2.46%
ABL.SG Abbott Laboratories
110.38
+0.44%